Dace Svikis

Dr. Dace Svikis


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
JMJennifer I. Manuel
Jennifer I. Manuel
YYYeqing Yuan
Yeqing Yuan
DHDaniel B. Herman
Daniel B. Herman
DSDace Svikis
Dace Svikis
ONObie Nichols
Obie Nichols
SDSherry Deren
Sherry Deren

7 July 2015 in Current Treatment Options in Psychiatry
Verified
Journal Article
Open access
PDF file
KPKathryn Polak
Kathryn Polak
NHNancy A. Haug
Nancy A. Haug
HDHaroldo E. Drachenberg
Haroldo E. Drachenberg
DSDace Svikis
Dace Svikis
Opinion statement Individuals with substance use disorders (SUD) are heterogeneous, making comprehensive assessment an essential part of treatment planning. Since a variety of pharmacological and psychosocial treatments are available, patient needs and characteristics, as well as substance-specific treatment options must be taken into account. In particular, clinicians should consider patient gender, as well as hormonal and other biological factors, when making treatment recommendations. Women are at greater risk for a variety of medical and psychosocial consequences, and may benefit from pharmacological and/or behavioral therapies that differ from those most beneficial for men. Pregnancy and gender identity also warrant special consideration. It is imperative that clinicians keep informed about new research findings that can guide tailoring of evidence-based treatments for men and women with SUD. Looking ahead, the field of pharmacogenomics offers additional promise for identifying the most effective pharmacotherapies for specific patients with SUD.

1 January 2012 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
DSDace Svikis
Dace Svikis
LKLori Keyser-Marcus
Lori Keyser-Marcus
MSMaxine Stitzer
Maxine Stitzer
TRTraci Rieckmann
Traci Rieckmann
LSLauretta Safford
Lauretta Safford
JZJoan Zweben
Joan Zweben

1 June 1994 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
DMDaniel R. McLeod
Daniel R. McLeod
GFGiraud V. Foster
Giraud V. Foster
RHRudolf Hoehn‐Saric
Rudolf Hoehn‐Saric
DSDace Svikis
Dace Svikis
PHPamela A. Hipsley
Pamela A. Hipsley

1 December 2016 in Preventive Medicine Reports
Verified
Journal Article
Open access
KPKathryn Polak
Kathryn Polak
PDPamela Dillon
Pamela Dillon
JKJ. Randy Koch
J. Randy Koch
WMWillis G. Miller
Willis G. Miller
LTLeroy Thacker
Leroy Thacker
DSDace Svikis
Dace Svikis
The increasing prevalence of energy drink (ED) use and its link with negative behaviors and adverse health outcomes has garnered much attention. Use of EDs combined with alcohol among college students has been of particular interest. It is unclear if these relationships develop in the context of college, or if similar associations exist in younger individuals. The present study examined associations between ED consumption patterns and other substance use in an adolescent, school-based sample. Participants were N = 3743 students attending 8th, 10th or 12th grade in a suburban central Virginia public school system who completed a prevention needs assessment survey in 2012. Chi-square analyses and logistic regressions were used to compare rates of alcohol, tobacco and other drug use across three ED use groups: moderate/heavy (12.6%), light (30.5%), and non-users (57%). Over 40% of the sample reported recent (past month) ED use, with males more likely to report moderate/heavy ED use than females (14.0% and 11.1%, respectively; p = 0.02). After adjusting for gender and grade, ED use group predicted lifetime alcohol, tobacco and other drug use (all p < 0.001). Moderate/heavy ED users were most likely and ED non-users were least likely to report using each of the 13 substances in the survey, with light ED users intermediate to the other two groups. Moderate/heavy ED users were consistently most likely to report licit and illicit substance use. Additional research is needed to better understand which adolescents are at greatest risk for adverse health behaviors associated with ED use.

1 November 2001 in Nicotine & Tobacco Research
Verified
Journal Article
Closed access
PDF file
NHNancy A. Haug
Nancy A. Haug
MSMaxine L. Stitzer
Maxine L. Stitzer
DSDace Svikis
Dace Svikis
The present study characterized cigarette smoking patterns (self-report, carbon monoxide, and cotinine), health-risk perceptions, attitudes, and quitting intentions among pregnant methadone-maintained women (n = 50) enrolled in comprehensive perinatal drug treatment. At baseline, women expressed only moderate motivation and self-efficacy for smoking cessation, and 60% were in the precontemplation stage of change for quitting. Follow-up assessment during pregnancy (n = 40) showed no change in self-reported cigarettes per day or cotinine values. Despite recognition of the personal and fetal health risks of smoking and high social support for quitting, none of the women stopped smoking and few demonstrated reduction. Compared to other pregnant smokers, this sample is characterized by many of the factors associated with difficulty in quitting. Innovative harm-reduction strategies and nicotine replacement medications deserve scientific attention in this high-risk group of tenacious smokers.